Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyApar Kishor Ganti, Miranda Hughes, Anne C. Chiang et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 459
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey Liveringhouse, Bradford A. Perez, Kujtim Latifi et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 18